PHARMACOKINETICS AND TISSUE PENETRATION OF ENOXACIN

被引:57
作者
WISE, R
LOCKLEY, R
DENT, J
WEBBERLY, M
机构
关键词
D O I
10.1128/AAC.26.1.17
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:17 / 19
页数:3
相关论文
共 11 条
[1]  
ADHAMI Z, 1983, J ANTIMICROB CHEMOTH, V13, P87
[2]   INVITRO ACTIVITY OF CI-919 (AT-2266), AN ORAL ANTI-PSEUDONOMAL COMPOUND [J].
CHARTRAND, SA ;
SCRIBNER, RK ;
WEBER, AH ;
WELCH, DF ;
MARKS, MI .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) :658-663
[3]   INVITRO ACTIVITY OF ENOXACIN, A QUINOLONE CARBOXYLIC-ACID, COMPARED WITH THOSE OF NORFLOXACIN, NEW BETA-LACTAMS, AMINOGLYCOSIDES, AND TRIMETHOPRIM [J].
CHIN, NX ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) :754-763
[4]   PHARMACOKINETICS AND TISSUE PENETRATION OF CIPROFLOXACIN [J].
CRUMP, B ;
WISE, R ;
DENT, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) :784-786
[5]  
GLADTKE E, 1979, PHARMACOKINETICS INT, P58
[6]   DRUG-THERAPY - CLINICAL PHARMACOKINETICS .1. [J].
GREENBLATT, DJ ;
KOCHWESER, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (14) :702-705
[7]   INVITRO ANTI-BACTERIAL PROPERTIES OF AT-2266, A NEW PYRIDONECARBOXYLIC ACID [J].
NAKAMURA, S ;
MINAMI, A ;
KATAE, H ;
INOUE, S ;
YAMAGISHI, J ;
TAKASE, Y ;
SHIMIZU, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) :641-648
[8]  
OSAKI T, 1981, CHEMOTHERAPY S4, V24, P128
[9]   NORFLOXACIN DISPOSITION AFTER SEQUENTIALLY INCREASING ORAL DOSES [J].
SWANSON, BN ;
BOPPANA, VK ;
VLASSES, PH ;
ROTMENSCH, HH ;
FERGUSON, RK .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (02) :284-288
[10]   THE INFLUENCE OF PROTEIN-BINDING UPON TISSUE-FLUID LEVELS OF 6 BETA-LACTAM ANTIBIOTICS [J].
WISE, R ;
GILLETT, AP ;
CADGE, B ;
DURHAM, SR ;
BAKER, S .
JOURNAL OF INFECTIOUS DISEASES, 1980, 142 (01) :77-82